Published in Stem Cells Int on February 23, 2017
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Apoptosis: a review of programmed cell death. Toxicol Pathol (2007) 17.92
Acute liver failure. Lancet (2010) 3.39
Apoptosis: a mechanism of acute and chronic liver injury. Gut (2005) 2.33
Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration. Hepatology (2010) 1.82
The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol (2008) 1.50
Effects of bone marrow and hepatocyte transplantation on liver injury. J Surg Res (2009) 1.46
Cell therapy for liver disease: From liver transplantation to cell factory. J Hepatol (2015) 1.41
Acute liver failure. Semin Respir Crit Care Med (2012) 1.40
Rodent models of partial hepatectomies. Liver Int (2007) 1.39
Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int (2010) 1.38
Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications. Arch Pharm Res (2012) 1.37
The role of apoptosis-induced proliferation for regeneration and cancer. Cold Spring Harb Perspect Biol (2012) 1.28
Transdifferentiation of bioencapsulated bone marrow cells into hepatocyte-like cells in the 90% hepatectomized rat model. Liver Transpl (2006) 1.28
Cell therapies for liver diseases. Liver Transpl (2012) 1.24
Liver regeneration by stem/progenitor cells. Hepatology (2014) 1.17
Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms. Blood (2012) 1.14
Acute liver failure: mechanisms of hepatocyte injury and regeneration. Semin Liver Dis (2008) 1.09
Comparing the Immunomodulatory Properties of Bone Marrow, Adipose Tissue, and Birth-Associated Tissue Mesenchymal Stromal Cells. Front Immunol (2015) 1.06
Rat liver regeneration after 90% partial hepatectomy. Hepatology (1984) 1.05
Liver regeneration is impaired in macrophage colony stimulating factor deficient mice after partial hepatectomy: the role of M-CSF-induced macrophages. J Surg Res (2009) 1.02
IL-6 pathway in the liver: From physiopathology to therapy. J Hepatol (2016) 0.96
Lesson from the GFP/CCl4 model--translational research project: the development of cell therapy using autologous bone marrow cells in patients with liver cirrhosis. J Hepatobiliary Pancreat Surg (2005) 0.91
Deceleration of regenerative response improves the outcome of rat with massive hepatectomy. Am J Transplant (2010) 0.89
The value of microsurgery in liver research. Liver Int (2009) 0.88
Cell-based therapy for acute and chronic liver failures: distinct diseases, different choices. Sci Rep (2014) 0.85
A pilot study of autologous CD34-depleted bone marrow mononuclear cell transplantation via the hepatic artery in five patients with liver failure. Cytotherapy (2013) 0.84
Adult derived mononuclear bone marrow cells improve survival in a model of acetaminophen-induced acute liver failure in rats. Toxicology (2008) 0.81
Cell microencapsulation: a potential tool for the treatment of neuronopathic lysosomal storage diseases. J Inherit Metab Dis (2011) 0.80
Platelet increases survival in a model of 90% hepatectomy in rats. Liver Int (2013) 0.79
Bone marrow mononuclear cell transplantation improves survival and induces hepatocyte proliferation in rats after CCl(4) acute liver damage. Dig Dis Sci (2010) 0.79
Pathophysiological Significance of Hepatic Apoptosis. ISRN Hepatol (2012) 0.79
The effects of anesthetic regimen in 90% hepatectomy in rats. Acta Cir Bras (2012) 0.78
Intraportal Infusion of Bone Marrow Mononuclear or CD133+ Cells in Patients With Decompensated Cirrhosis: A Double-Blind Randomized Controlled Trial. Stem Cells Transl Med (2015) 0.77
Endotoxin-stimulated Rat Hepatic Stellate Cells Induce Autophagy in Hepatocytes as a Survival Mechanism. J Cell Physiol (2016) 0.77
Encapsulated Whole Bone Marrow Cells Improve Survival in Wistar Rats after 90% Partial Hepatectomy. Stem Cells Int (2015) 0.76
Bone Marrow Mesenchymal Stem Cells Reverse Liver Damage in a Carbon Tetrachloride-induced Mouse Model of Chronic Liver Injury. In Vivo (2016) 0.76